APYX

Conviction 64HealthcareScan · Mon, Aug 10, 2026

APYX$3.46-14.57%

ResistanceSupportVol 14

Vol MA14 92.43K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Apyx Medical CorpSURGICAL & MEDICAL INSTRUMENTS & APPARATUSapyxmedical.com ↗

Price3.46

Change-14.57%

Gap-5.19%

Rel volume1.46×

Avg volume80.82K

Avg $ vol327.35K

SMA 204.06

SMA 504.22

SMA 2003.85

Price vs 50-18.09%

Price vs 200-10.15%

MA stackmixed

50/200 cross—

Supertrenddown · 4.52

RSI (14)34

MACD hist-0.03

MACD crossbear · 0d

Stoch %K / %D6 / 45

ADX (14)16

+DI / −DI17 / 24

RSI divergence—

MACD divergence—

ATR %+9.74%

ADR %7.20%

52w high4.86

52w low1.90

From 52w high-28.81%

Above 52w low+82.11%

New 52w highNo

SqueezeOn · 6d

Bollinger width21.39%

%B-0.19

Donchian pos5.50%

Donchian high4.49

Donchian low3.40

AVWAP (52w high)4.31

vs AVWAP high-19.70%

AVWAP (52w low)3.77

vs AVWAP low-8.18%

OBV trendDown

Chaikin MF (20)-0.01

Today vs 20d1.46×

Avg vol (14d)92.42K

Avg vol (20d)80.82K

Avg $ vol (20d)327.35K

Market cap—

RS 3m (vs SPY)+8.07%

RS 6m (vs SPY)-11.32%

RS line new highNo

Trend template5/8

Technical rank13.9

1 week-17.22%

1 month-21.00%

3 months-5.72%

6 months-10.82%

1 year+76.53%

YTD-1.14%

P/E-15.03

P/B15.80

P/S3.19

P/FCF-18.49

EPS-0.5400

Div yield—

ROE-105.14%

ROA-18.36%

Debt/Eq4.15

Current5.68

EV/EBITDA-31.96

Gross margin62.53%

Net margin-21.22%

Rev growth9.86%

EPS growth52.22%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value185.1M

Revenue13.88M

Net income-3.24M

Gross profit8.87M

Free cash flow-9.12M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out41.87M

Employees205

ListedWed, Apr 6, 1994

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction64 / 100

Pattern quality—

Tech rank13.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.86

Support3.77

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APYX

All disclosures →

No recent disclosed trades by Congress in APYX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APYX · 1 buy · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Roman Shawn David Chief Operating Officer · Common Stock · 2026-06-15	Exercise	15K	$48K	2026-06-15	2026-06-17
Roman Shawn David Chief Operating Officer · Common Stock · 2026-06-15	Tax	10.53K	$48K	2026-06-15	2026-06-17
Roman Shawn David Chief Operating Officer · Stock option (right to buy) · 2026-06-15	Exercise	15K	—	2026-06-15	2026-06-17

SEC filings

EDGAR filings in APYX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.